A New Extended-Release Levodopa Formulation
In August 2024, the FDA approved a new Parkinson’s medication, CREXONT®. CREXONT, which was developed by Amneal, is a …
In August 2024, the FDA approved a new Parkinson’s medication, CREXONT®. CREXONT, which was developed by Amneal, is a …